China
Navigate forward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
Navigate backward to interact with the calendar and select a date. Press the question mark key to get the keyboard shortcuts for changing dates.
Featured
China Is Rapidly Becoming a Leading Innovator in Advanced Industries

There may be no more important question for the West’s competitive position in advanced industries than whether China is becoming a rival innovator. While the evidence suggests it hasn’t yet taken the overall lead, it has pulled ahead in certain areas, and in many others Chinese firms will likely equal or surpass Western firms within a decade or so.
More Publications and Events
June 30, 2025|Blogs
If They Told You Wolverines Would Make Good House Pets, Prime Minister, Would You Believe Them?
If the Starmer government thinks for one minute that the PRC will allow the UK to expand exports of anything with any real strategic importance, it is gravely mistaken. It’s time for competitive realism.
June 23, 2025|Blogs
Fact of the Week: China and the EU Invest More in Research at Government Institutions and Universities Than the US
In 2023, the United States invested about $175 billion in research conducted at government institutions and universities. That same year, the EU invested about $180 billion, and China about $200 billion.
June 11, 2025|Blogs
How Policymakers Can Stop Chinese Copycat Commerce
Chinese e-commerce platforms are profiting from large-scale design theft that undermines independent creators on sites like Etsy. U.S. policymakers should respond with stronger IP enforcement and trade regulations to protect the American creative economy.
June 10, 2025|Op-Eds & Contributed Articles
Anti-Counterfeiting Efforts Must Hold China Accountable
In Law360, Eli Clemens argues that international anti-counterfeiting efforts must directly confront China’s central role in the counterfeit trade, or risk rendering global enforcement guidelines ineffective.
June 9, 2025|Blogs
Fact of the Week: China Has Surpassed the US in the Number of Drug Clinical Trials, With 1,100 More Trials Listed
China listed 7,100 clinical trials in 2024, while the United States held 6,000.
June 5, 2025|Presentations
Stakeholder Comments Regarding OECD Online Marketplace Guidelines
Eli Clemens spoke at a stakeholder roundtable discussion hosted by the OECD and the U.S. Patent & Trademark Office. Clemens urged the OECD to confront China's role as the main source of counterfeit goods in global ecommerce.
May 13, 2025|Blogs
Foreign Reference Pricing: A Fast Track to Losing America’s Biopharmaceutical Edge to China
The Trump administration’s “MFN” drug-price proposal would pose a far greater threat to U.S. biopharma innovation than the Inflation Reduction Act, because unlike the IRA’s selective list, MFN could apply across virtually every medicine, multiplying the deleterious impact.
May 12, 2025|Op-Eds & Contributed Articles
Never Fight a Multifront Trade War: Why the United States Will Lose
Chinese advanced industries may not have U.S. market access after the trade war, but they will have the rest of the world’s. American companies will be left with the scraps of the U.S. market. Scale will determine the winner.
May 9, 2025|Blogs
China’s “Minor Mode”: Blueprint or Cautionary Tale?
China’s new “minor mode” gives parents customizable tools to manage children’s online activity—offering a rare, less-restrictive model within China’s otherwise authoritarian digital policy that the U.S. can draw from while maintaining democratic values.
May 5, 2025|Testimonies & Filings
Comments to the UK Parliament Foreign Affairs Committee Regarding the UK Government’s China Audit
ITIF offered comments on evidence the UK government should draw on; short- and long-term objectives for the UK-China relationship; areas to engage with China, and areas to draw red lines; how engagement could affect other alliances; and how to assess dependencies on China while strengthening security and resilience.